DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name ▲ | UniProt ID |
---|---|---|---|---|---|
C0038356 | Stomach Neoplasms | MGAT5 | 4249 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase | Q09328 |
C0020459 | Hyperinsulinism | MGAT5 | 4249 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase | Q09328 |
C1621958 | Glioblastoma Multiforme | MGAT5 | 4249 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase | Q09328 |
C0699791 | Stomach Carcinoma | MGAT5 | 4249 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase | Q09328 |
C0017636 | Glioblastoma | MGAT5 | 4249 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase | Q09328 |
C0700095 | Central neuroblastoma | MGAT5B | 146664 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B | Q3V5L5 |
C1136382 | Sclerocystic Ovaries | MGAT5B | 146664 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B | Q3V5L5 |
C0027819 | Neuroblastoma | MGAT5B | 146664 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B | Q3V5L5 |
C0006826 | Malignant Neoplasms | MGAT5B | 146664 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B | Q3V5L5 |
C0153633 | Malignant neoplasm of brain | MGAT5B | 146664 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B | Q3V5L5 |
C2239176 | Liver carcinoma | MGAT5B | 146664 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B | Q3V5L5 |
C0279702 | Conventional (Clear Cell) Renal Cell Carcinoma | MGAT5B | 146664 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B | Q3V5L5 |
C0016788 | Fucosidase Deficiency Disease | FUCA1 | 2517 | alpha-L-fucosidase 1 | P04066 |
C1527336 | Sjogren's Syndrome | FUCA1 | 2517 | alpha-L-fucosidase 1 | P04066 |
C0036572 | Seizures | FUCA1 | 2517 | alpha-L-fucosidase 1 | P04066 |
C0086795 | Pfaundler-Hurler Syndrome | FUCA1 | 2517 | alpha-L-fucosidase 1 | P04066 |
C0006142 | Malignant neoplasm of breast | FUCA1 | 2517 | alpha-L-fucosidase 1 | P04066 |
C0040136 | Thyroid Neoplasm | FUCA1 | 2517 | alpha-L-fucosidase 1 | P04066 |
C0006826 | Malignant Neoplasms | FUCA1 | 2517 | alpha-L-fucosidase 1 | P04066 |
C0020676 | Hypothyroidism | FUCA1 | 2517 | alpha-L-fucosidase 1 | P04066 |
C1306459 | Primary malignant neoplasm | FUCA1 | 2517 | alpha-L-fucosidase 1 | P04066 |
C1384666 | hearing impairment | FUCA1 | 2517 | alpha-L-fucosidase 1 | P04066 |
C0162819 | Skin Diseases, Vascular | FUCA1 | 2517 | alpha-L-fucosidase 1 | P04066 |
C0235946 | Cerebral atrophy | FUCA1 | 2517 | alpha-L-fucosidase 1 | P04066 |
C0027533 | Neck Neoplasms | FUCA1 | 2517 | alpha-L-fucosidase 1 | P04066 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024